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Abstract
Nonhuman primates provide an important opportunity to define the mechanisms that contribute
to the success of early pregnancy. We have focused for several years now on defining the
expression of novel placental major histocompatibility complex (MHC) class I molecules. In parallel,
we have used reagents against human immune cell markers to characterize the leukocyte
population in the decidua and have demonstrated dynamic changes in these cell populations during
the first 5 weeks of gestation. The challenge is to identify the possible role(s) of placental MHC
class I in modifying/directing the maternal endometrial or systemic immune system in the post-
implantation period. Foremost among the challenges is the difficulty in modifying placental function.
In the instance of trophoblast surface proteins, passive immunization studies are feasible, although
limitations include the empirical nature of this approach, as well as the inability to modify
intracellular function. We have shown that using lentiviral vectors to effect preimplantation gene
transfer for transgene expression in the placenta is not only feasible, but of good efficiency. In
addition to transgene overexpression, robust approaches for knocking down/knocking out
placental gene expression are essential. Recent developments in RNA interference approaches may
allow "transient knockout" experiments. While the rhesus monkey has been our model of choice,
currently there are limitations in the number of available female rhesus monkeys of reproductive
age for research in early pregnancy. It is critical that the technologies for advanced study move
forward in other species. The baboon has been used significantly in reproductive tract biology and
early pregnancy research and important models have been developed for manipulation of the
maternal-fetal interface. Additional characterization of other species, such as the cynomolgus and
African green (vervet) monkey is critical. Given the limitations on antigen recognition when using
human reagents, we also propose that the development of panels of primate-specific anti-leukocyte
antibodies is essential for moving forward nonhuman primate reproductive research.
Background
Early pregnancy represents a fundamentally critical time
in the human life cycle. The establishment of human preg-
nancy is of surprisingly low efficiency, with estimates of
pregnancy loss during the first weeks following fertiliza-
tion as high as 50% [1]. Once established, the success of
maternal and fetal health is far from assured, with preec-
lampsia, fetal growth restriction, prematurity or postma-
turity contributing significantly to fetal as well as maternal
morbidity and mortality. Finally, even if a pregnancy is
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successfully carried to completion, it does not insure post-
natal well-being. There is now widespread recognition
that a major contributor not only to neonatal health and
well-being, but physiology throughout the lifespan is dra-
matically influenced by the intrauterine environment [2].
There is wide recognition that the placenta has a profound
impact in many of these areas of development, however,
human pregnancy remains an extremely challenging area
for the conduct of clinical research. Invasive studies to
determine the influences of placental manipulation are
extremely difficult to design because of the special ethical
case that a pregnant woman represents, recognizing that
interventions which might provide risk to the fetus are not
generally acceptable. In addition, it is extraordinarily rare
to be able to conduct basic observational or descriptive
studies in the earliest stages of human pregnancy (i.e.,
within several weeks of implantation).
The nonhuman primate represents an important model
for understanding basic human biology, and testing ther-
apeutic interventions. A particularly important example of
this is in early pregnancy. Nonhuman primates have been
shown to be excellent models for studying preimplanta-
tion embryo development and postimplantation physiol-
ogy [3,4]. Indeed, many of the aspects of human
preimplantation embryo development, such as the initia-
tion of the expression of chorionic gonadotropin genes,
are recapitulated in rhesus monkey embryos similar to
human embryos. Careful description of the perimplanta-
tion anatomy and development of the placenta and the
fetal membranes has been feasible with the nonhuman
primate. Finally, experiments to directly intervene in fetal
or maternal physiology to understand the outcome in
fetal development (e.g., studies in developmental toxicol-
ogy) are readily accomplished in nonhuman primates.
Thus, nonhuman primates provide an important oppor-
tunity to define the mechanisms that contribute to the
success of early pregnancy. In this report we will review
progress in the development of a nonhuman primate
model for investigating one area of human pregnancy, the
establishment of maternal-fetal immune tolerance. We
will describe the approaches we have developed to
address the challenges that face investigators in this area,
and we will summarize opportunities to address the chal-
lenges that remain.
Case study in nonhuman primate pregnancy 
research – development of a primate model for 
maternal-fetal immune tolerance
Advances in the 20th century in our understanding of
immune mechanisms of transplant rejection revealed that
mammalian pregnancy poses a novel challenge to fetal
survival. The tolerance of the paternal component of the
fetal genome, particularly the polymorphic MHC class I
genes, has intrigued reproductive biologists for half a cen-
tury. This question is all the more intriguing given the
realization that the solutions that have evolved across dif-
ferent mammalian orders is diverse in the extreme (Table
1). For example, mice have been reported to have no tro-
phoblast MHC expression, wheras, horses normally
Table 1: Comparison of nonprimate and primate placental MHC biology
bovine:
• trophoblasts lack MHC class I expression [5]
• Trophoblasts from cloned fetuses express MHC class I, cow has altered endometrial immune cells [5]
horse:
• trophoblasts express classical MHC class I [6]
• mare raises an alloresponse to paternal MHC [7]
mice:
• no trophoblast MHC class I [8]
• pregnancy is successful despite transgenic MHC expression (or β2 m knockout) [8, 9]
• disruption of T cell or complement regulation detrimental to pregnancy success [10, 11]
nonhuman primate:
• lack of functional HLA-G locus [28]
• nonclassical MHC class I expression: Mamu-AG [29], Mamu-E [30]
• novel MHC class I expression, Mamu-I [31]
human:
• extravillous trophoblast HLA-G expression [12, 13]
• abundant placental nonclassical MHC expression (HLA-E, HLA-F) [15,22]
• placental HLA-C expression in some cytotrophoblasts [14]
HLA-G homologs have not been identified in nonprimate speciesReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/35
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express paternal and maternal MHC class I in the endome-
trial cups and raise an antipaternal MHC response in the
mare.
Perhaps the most significant attention has been allotted to
human placental MHC, given the broad palette of rea-
gents and information on human MHC expression. While
human trophoblasts do not express MHC Class II mole-
cules, human trophoblasts express a novel pattern of pri-
marily nonclassical MHC class I (HLA-E, -F and G) as well
as limited HLA-C expression [12-15]. In particular, since
HLA-G expression is largely restricted to placental tro-
phoblasts, it has received significant investigation by
reproductive biologists.
In vitro studies with human trophoblasts and immune
cells have suggested that there are specific receptors for
HLA-G on various maternal leukocyte compartments.
These compartments include the novel population of
uterine natural killer cells also known previously as decid-
ual large granular lymphocytes [16], as well as endome-
trial macrophages and possibly dendritic cells [17-19].
The identity of this latter cell type remains controversial
[18,19]. Previously it had been hypothesized that tro-
phoblast nonclassical MHC class I molecules served to
avoid the problems that would be imposed by expression
of paternal MHC on trophoblasts exposed directly to
maternal immune cells. In the absence of any MHC class
I, NK cells would be activated by lack of self to mount an
immune response to the placenta. Indeed, NK cell inhibi-
tory receptors (KIRs) are expressed on uterine NK cells and
may function as HLA-G receptors, however this remains a
matter of contention [20,21]. It is clear that HLA-E recep-
tors are widely expressed in NK cells, including those in
the decidua [22]. In contrast, monocyte-derived cells
express a related family of Leukocyte Ig-like Receptors
(LILRs), and two of these (LILRB1/ILT2, LILRB2/ILT4/
LIP2) are putative HLA-G receptors [23,24].
Regardless of the receptor identity, the effects of placental
MHC molecules may not simply be to down-regulate anti-
trophoblast immune responses. Although information in
humans or primates is limited, in mice there is substantial
literature that describes an important role of uterine leu-
kocytes in pregnancy success despite the lack of MHC
expression on mouse trophoblasts. Mice with compo-
nents of the nonspecific immune system deleted by
homologous recombination have defects in decidual dif-
ferentiation and vascular development [25] indicating
that pregnancy success may rely on the presence and func-
tion of nonspecific immune cells, i.e., NK cells. With
regard to human placental MHC, much interest has also
arisen centered on not only local immunity, but the pos-
sible effects of HLA-G in the peripheral circulation on
extrauterine tolerance, not only in the setting of preg-
nancy [26], but as well in cancer and transplantation med-
icine [27]. Thus understanding the biological function of
nonclassical MHC expression has significance beyond the
setting of pregnancy.
Despite this substantial interest, well over a decade of
research into the expression of HLA-G and its effects on
the maternal immune system has failed to precisely iden-
tify a significant function for the molecule. Much less even
still is known about the relative contributions the other
placental MHC class I molecules make to maternal toler-
ance of pregnancy. For this reason, it was necessary to
understand whether an animal model may serve in func-
tional studies of maternal-fetal immune tolerance.
We have defined the MHC class I expression within the
rhesus monkey placenta. Intriguingly, the rhesus monkey
does not express a functional HLA-G ortholog [28], but
expresses at a high level a locus actually derived from rhe-
sus MHC A [29]. Nonetheless, this locus (which we desig-
nated Mamu-AG) retains novel characteristics associated
with HLA-G, including a shortened cytoplasmic domain,
novel mRNA splicing, expression of glycosylation iso-
forms, and predominant protein expression within the
placenta. The rhesus placenta also expresses the mRNAs
for Mamu-E [30] and a novel locus in the rhesus desig-
nated Mamu-I [31]. The protein expression of these mole-
cules has not been fully explored. Of particular interest is
that we have shown that within a week of implantation,
Mamu-AG protein expression is readily detectable within
the invasive trophoblasts penetrating the uterine decidual
stroma, as well as endovascular trophoblasts within
maternal decidual blood vessels [32]. It is critical to note
that this observation is unlikely to have been made in
human pregnancy, due to the virtual unavailability of 1
week implantation sites for such analysis. Our studies
with Mamu-AG, as well as others with HLA-G, have clearly
shown the importance of highly specific antibodies
because of the likely translational control of MHC class I
expression. Although Mamu-E and -I mRNAs are found in
the placenta, confirmation of their protein expression
awaits the characterization of antibodies specifically rec-
ognizing these rhesus proteins.
Decidual immune cells
The maternal side of the primate maternal-fetal interface
is equally fascinating. Primate pregnancy is characterized
by the appearance of a unique population of resident tis-
sue leukocytes. A majority of these cells are large granular
natural killer (NK) cells, termed uterine NK (uNK) cells.
The phenotype of these cells in both human and nonhu-
man primate pregnancy is distinct from peripheral blood
NK cells, notably with high levels of expression of CD56
(NCAM-1) [33]. It remains unclear whether these cells are
resident cells expanded by the initiation of pregnancy, ifReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/35
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they arise due to trafficking and differentiation of periph-
eral blood NK cells to the decidua, or if both mechanisms
are at play. In addition to these NK cells, there is a modu-
lation and modification of decidual macrophages in the
first months of human and monkey pregnancy. While it
has been recognized that macrophages are present in sub-
stantial numbers in the first trimester human decidua, we
have recently undertaken to delineate this population in
the earliest stages of rhesus monkey pregnancy, within 1
to 3 weeks postimplantation. Unexpectedly, there were
distinct differences in the distribution of macrophages
around the invading interstitial and endovascular tro-
phoblasts [34]. Whereas NK cells were relatively uni-
formly distributed throughout the decidua and did not
give the distinct impression of selective localization, mac-
rophages were in many cases clearly preferentially located
in close proximity to the trophoblasts. This is in keeping
with recent reports of expression of chemokines and mac-
rophage attractant proteins to the human implantation
site [35], although macrophage distribution is not as dra-
matic as in these early pregnancy images. It would appear
that macrophage-trophoblast interactions may very well
be one of the earliest placental-immune interactions.
Developing approaches for placental 
manipulation – ART in support of primate 
transgenesis
The expression of placental MHC and the phenotype and
appearance of nonhuman primate decidual leukocytes is
supportive of the relevance of this animal model to
human pregnancy. In reality it becomes clear that it is very
difficult to conduct invasive studies to disrupt placental
function. The problem is that classical ablation-replace-
ment experiments such as those to investigate the hypoth-
alamic-pituitary-ovarian reproductive axis are not relevant
in a pregnant monkey. The potential opportunities seem
limited to passive immunization, which can be fruitful
but has significant drawbacks, including the empirical
nature of such experiments, and perhaps treatment with
soluble placental MHC class I to determine effects on sys-
temic immunity.
For a solution to this dilemma, we considered the origin
of the placenta. Since the placental trophoblasts arise
from the trophectoderm of the preimplantation embryo,
we selected IVF-produced or in vivo recovered embryos as
a target for placental modification, via placental transgen-
esis. Although the methods of transgenesis are well-estab-
lished in mice and clearly feasible in other species, the
relative scarcity of rhesus embryos as well as the logistical
difficulties of synchronization and surrogate embryo
recipient identification compelled us to consider ways to
improve the efficiency of gene transfer. We elected to
adapt the tools of the gene therapy researcher to obtain
high efficiency transfer to embryos. We considered and
conducted studies with plasmid-based EBV vectors [36],
adeno-associated virus type 2 [37], which had low effi-
ciency of gene transfer in rhesus embryos (Wolfgang and
Golos, unpublished observations), and ultimately settled
on lentiviral-based vectors [38]. Using a green fluorescent
protein (GFP) transgene, we found relatively reliable GFP
expression within several days of gene transfer (Fig. 1). We
conducted 24 transcervical nonsurgical transfers of GFP-
transduced IVF or in vivo recovered embryos (Table 2). An
important facet of these studies is that the animal care
staff working with these animals had years of experience
with their reproductive cycles and patterns, including pre-
vious pregnancies. Interestingly, the transfer of GFP-trans-
duced embryos suggested a broader window of
implantation to that previously determined [39] for
"wild-type" embryos. It may be that gene transfer alters
embryonic development such that asynchrony between
embryo and recipient is not as detrimental as in transfer
of unmodified embryos.
At the time of delivery, we noted excellent transgene
expression in placentas from all offspring, including a lost
twin pregnancy [38]. However, evidence for transgene
expression in cord blood cells or skin cells of the offspring
was lacking [38], and subsequent follow-up studies have
likewise failed to detect extraplacental GFP protein expres-
sion in PBLs (Garthwaite et al, unpublished observa-
tions). Site-of-integration effects are well-known in
transgenesis, but it seems surprising that of three offspring
there would be a lack of transgene expression and further
studies of these individuals are ongoing. Significantly,
placental transgene expression was tolerated by the mater-
nal immune system, even in the face of a robust immune
response by the dam [38]. Additional study of the dams is
also warranted and this is an advantage of the nonhuman
primate model, in which we can study subsequent preg-
nancies potentially over many years.
Conclusions – limitations, challenges and future 
opportunities in primate maternal-fetal 
medicine research
There are opportunities as well as challenges in manipu-
lating the placental phenotype in the primate. Whereas
overexpression of a selected gene can be of value, of per-
haps greater broad importance will be the development of
gene-knockdown approaches. Standard gene deletion by
homologous recombination will require advances in
embryonic stem cell technologies with rhesus monkey ES
cells, but a viable alternative is the use of RNAi technology
within the lentiviral system [40]. Other areas of interest
are listed in Table 3.
Table 4 lists additional important priority areas in preg-
nancy research with the nonhuman primate model. One
of the critical limitations in the use of the rhesus monkeyReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/35
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Brightfield (left) and fluorescent (right) images of lentivirus-transduced rhesus monkey preimplantation embryos Figure 1
Brightfield (left) and fluorescent (right) images of lentivirus-transduced rhesus monkey preimplantation 
embryos. IVF-derived embryos were injected with lentivirus stock with GFP expression under the control of the EF-1α pro-
moter. Injections were done at the 8–16 cell stage (60 hrs postinsemination (PI), Panel A) and embryos were imaged at 10–12 
hour intervals thereafter. Most embryos were at the blastocyst stage within 4 days (panels I, J).Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/35
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is simply the availability of sufficient numbers of animals
to conduct embryo transfers with modified embryos. A
substantial pool of animals is needed in the absence of
reliable synchronization of recipient cycles, and this will
remain a limitation when these methods become availa-
ble, given the long (165 day) gestation period of this spe-
cies. Dramatically expanding the rhesus monkey
population at the National Primate Research Centers is
one critical need.
The development of basic knowledge in the reproductive
biology and physiology of pregnancy in additional species
with close similarities to human pregnancy is also impor-
tant. The baboon (Papio anubis) already is an excellent
model in early pregnancy research [41]. The cynomolgus
monkey (Macaca fasciculata) and African green (vervet)
monkey (Circopithecus aethiopes) have attractive charac-
teristics of size, cost, and in the vervet, a relatively straight
cervix to facilitate embryo transfer. The stimulation of
nonhuman primates with recombinant human gonado-
tropins remains the state of the art, and current efforts to
develop recombinant homologous nonhuman primate
hormones is critical to the long-term success of primate
transgenesis.
Finally, with regards to modification of the decidual
immune cells, fewer options are available. The study of
the reproductive immunology of these species suffers
from laborious and expensive testing of anti-human anti-
bodies to define appropriate reagents for identifying
antigens on nonhuman primate leukocytes. The develop-
ment of panels of primate-specific antibodies will not
only improve detection and phenotyping of monkey leu-
kocytes, but may facilitate the development of passive
immunization or immunodepletion strategies for probing
the function of reproductive tract immune cells in preg-
nancy success. When these approaches and resources
become available, investigators will have a dramatically
enhanced ability to bring molecular embryology, microar-
ray phenotyping, stem cell biology, and homologous
recombination into the arsenal of research in primate
reproduction.
Table 2: Outcome of transfer of embryos injected with lentiviral vector
Total Transfers Recipient Day Post LH Outcome
2 3 No pregnancy initiation
7 4 1 live/1 stillborn twin, 1 blighted ovum
8 5 4 blighted ova
3 6 1 live birth
3 7 1 live birth, 1 blighted ovum
1 8 1 early twin loss
24 3 live births, 8 lost pregnancies
Table 3: Challenges in manipulation of the placental phenotype
• Targeted delivery of vector to the placenta: promoter and receptor-based approaches
• Implementation of gene knock-down technology
• Regulated expression would be of significant utility
• Useful approaches will include minimally invasive monitoring of transgene expression during pregnancy
• Improvement in vector application (replacement vs. insertion)
• Alignment of enthusiasm with reality of resource availability = prioritization of research goals
Table 4: Opportunities and areas of growth in nonhuman primate pregnancy research
• Basic reproductive biology of additional primate species
• Reagents for reliable assisted reproductive technologies
• Forward implementation of improved embryo transfer and reconstitution technology
• Availability of nonhuman primate-specific antibodies
• Continued focus on cooperative training and collaborations among primate researchersReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/35
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